DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2956 | Krc-108 | Novel potent multi-kinase inhibitor, targeting Ron, Flt3 and TrkA as well as c-Met |
|
| DCC2957 | Krc-327 | Selective novel inhibitor of c-Met receptor tyrosine kinase with anticancer activity. |
|
| DCC2958 | Krm-ii-08 | Novel potent, non-toxic, blood-brain barrier crossing, α5-GABA A R preferring ligand, enhancing a chloride-anion efflux that induces mitochondrial membrane depolarization and in response, TP53 upregulation and p53, constitutively phosphorylated at S392, c |
|
| DCC2959 | Krn4884 | Potassium channel opener |
|
| DCC2960 | Krn-8602 Hydrochloride | Topo II inhibitor, exhibiting cytotoxic effects against tumour cells |
|
| DCC2961 | Krp-109 | Novel neutrophil elastase (NE) inhibitor, decreasing expression of TGF-ß Signal Related Genes |
|
| DCC2962 | Krp-199 | Highly potent and selective antagonist for the AMPA receptors, exhibiting good neuroprotective effects in vivo |
|
| DCC2963 | Krp-204 | Novel highly selective β3-adrenoceptor agonist being developed for the treatment of diabetes and obesity |
|
| DCC2964 | Ks-133 | Novel Potent and Selective VIPR2 Antagonist, Counteracting Cognitive Decline in a Mouse Model of Psychiatric Disorders |
|
| DCC2965 | Ksc-392-150 | Novel inhibitor of the permeability transition pore (PTP) |
|
| DCC2966 | kscm-1 | Selective ligand of the sigma-1 receptor |
|
| DCC2967 | Kscm-11 | Ligand of the sigma receptor |
|
| DCC2968 | kscm-5 | Ligand of the sigma receptor |
|
| DCC2969 | Ksk120 | Novel inhibitor of transcriptional activity in Chlamydia trachomatis |
|
| DCC2970 | Ksl-128114 | Novel, highly potent, and metabolically stable peptide inhibitor of syntenin, Inhibiting Glioblastoma |
|
| DCC2971 | Kspa-1 | Novel modulator of kinesin spindle protein (KSP)/Eg5, activating KSP-catalyzed ATP hydrolysis in the absence of microtubules yet inhibiting microtubule-stimulated ATP hydrolysis by KSP |
|
| DCC2972 | Kt-182 | Potent and selective inhibitor of ABHD6 |
|
| DCC2973 | Kt2-962 | TXA2/prostaglandin endoperoxide receptor antagonist |
|
| DCC2974 | Kta-439 | Thyroid hormone receptor β (TRβ) selective agonist |
|
| DCC2975 | Ku-2285 | Hypoxic cell radiosensitizer |
|
| DCC2976 | Kufal194 | Novel selective DYRK1A inhibitor |
|
| DCC2977 | Kunb31 | Novel potent and selective inhibitor of Hsp90β |
|
| DCC2978 | Kurasoin B | Novel protein farnesyltransferase inhibitor |
|
| DCC2979 | kv1.5-in-iiii | Potent Kv1.5 inhibitor |
|
| DCC2980 | Kv2.1/syntaxin-in-cpd5 | Novel neuroprotectant, inhibiting Kv2.1-syntaxin molecular interaction |
|
| DCC2981 | Kva-d-88 | Novel Preferable Phosphodiesterase 4B (PDE4B) Inhibitor, Decreasing Cocaine-Mediated Reward Properties in Vivo |
|
| DCC2982 | Ky1022 | Ras destabilizer, targeting the Wnt/ß-catenin pathway and inhibiting development of metastatic colorectal cancer |
|
| DCC2983 | Kya1797 | Novel inhibitor of the Wnt/ß-catenin pathway, binding directly to the regulators of G-protein signaling domain of axin, initiating ß-catenin and Ras degradation through enhancement of the ß-catenin destruction complex activating GSK3ß, effectively suppres |
|
| DCC2984 | Kys05047 | Selective T-type Ca(2+) channel blocker with anti-proliferative effects against various cancer cells |
|
| DCC2985 | L-161240 | Potent inhibitor of LpxC and lipid A biosynthesis |
|
